Global Oncology Molecular Diagnostic Market report is generated by a team of multilingual researchers who are skilled at different languages and hence perform market research internationally. With this report, businesses can get clear idea about how the market is going to perform in the forecast years with understan.
TOKYO and XIAMEN, China, March 27, 2023 Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., and Precision Medicine Asia Co., Ltd. today announced that the Japanese Ministry of Health, Labour. | March 27, 2023
Oncologists in Japan can now use the AmoyDx Pan Lung Cancer PCR Panel to identify patients with RET fusions that make them eligible for treatment with the Eli Lilly drug.
LC-SCRUM-Asia, a genomic screening project and database that initially launched in Japan in 2013, is expanding and will cover additional countries in the Asia-Pacific region.